| Product Code: ETC9405820 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Inherited Metabolic Disorders Testing Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Inherited Metabolic Disorders Testing Market - Industry Life Cycle |
3.4 South Korea Inherited Metabolic Disorders Testing Market - Porter's Five Forces |
3.5 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 South Korea Inherited Metabolic Disorders Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of inherited metabolic disorders in South Korea |
4.2.2 Technological advancements leading to more accurate and efficient testing methods |
4.2.3 Growing investments in healthcare infrastructure and research development in the country |
4.3 Market Restraints |
4.3.1 High cost associated with testing and treatment of inherited metabolic disorders |
4.3.2 Limited availability of specialized healthcare professionals and facilities for testing and diagnosis |
4.3.3 Stringent regulatory requirements for approval of testing kits and procedures |
5 South Korea Inherited Metabolic Disorders Testing Market Trends |
6 South Korea Inherited Metabolic Disorders Testing Market, By Types |
6.1 South Korea Inherited Metabolic Disorders Testing Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Hurler Syndrome, 2021- 2031F |
6.1.4 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Niemann-Pick Disease, 2021- 2031F |
6.1.5 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Tay-Sachs Disease, 2021- 2031F |
6.1.6 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Gaucher Disease, 2021- 2031F |
6.1.7 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Fabry Disease, 2021- 2031F |
6.1.8 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Krabbe Disease, 2021- 2031F |
6.2 South Korea Inherited Metabolic Disorders Testing Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Enzyme Replacement Therapy, 2021- 2031F |
6.2.3 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Cellular Transplantation, 2021- 2031F |
6.2.4 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Small Molecule Based Therapy, 2021- 2031F |
6.2.5 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Substrate Reduction Therapy, 2021- 2031F |
6.2.6 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2.7 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Drug Therapy, 2021- 2031F |
6.3 South Korea Inherited Metabolic Disorders Testing Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 South Korea Inherited Metabolic Disorders Testing Market, By End-user |
6.4.1 Overview and Analysis |
6.4.2 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Hospital and Clinics, 2021- 2031F |
6.4.3 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.4.4 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Blood Banks, 2021- 2031F |
6.4.5 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.4.6 South Korea Inherited Metabolic Disorders Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea Inherited Metabolic Disorders Testing Market Import-Export Trade Statistics |
7.1 South Korea Inherited Metabolic Disorders Testing Market Export to Major Countries |
7.2 South Korea Inherited Metabolic Disorders Testing Market Imports from Major Countries |
8 South Korea Inherited Metabolic Disorders Testing Market Key Performance Indicators |
8.1 Average turnaround time for test results |
8.2 Number of accredited laboratories offering inherited metabolic disorders testing |
8.3 Rate of adoption of new testing technologies |
8.4 Percentage of population screened for inherited metabolic disorders |
8.5 Patient satisfaction with testing services provided |
9 South Korea Inherited Metabolic Disorders Testing Market - Opportunity Assessment |
9.1 South Korea Inherited Metabolic Disorders Testing Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 South Korea Inherited Metabolic Disorders Testing Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 South Korea Inherited Metabolic Disorders Testing Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 South Korea Inherited Metabolic Disorders Testing Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 South Korea Inherited Metabolic Disorders Testing Market - Competitive Landscape |
10.1 South Korea Inherited Metabolic Disorders Testing Market Revenue Share, By Companies, 2024 |
10.2 South Korea Inherited Metabolic Disorders Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here